INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/14/2026
Back to search
Official data from USPTO
LENTIGLOBIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
07/14/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/30/2017
Registration date
04/30/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
07/14/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
KEAM, ALEX S
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genetix Biotherapeutics, Inc.
bluebird bio, Inc.
bluebird bio, Inc.
Bluebird Bio (UK) Ltd.
Representatives
John L. DuPre' Hamilton, Brook, Smith & Reynolds, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of genetic diseases
Publications
History of USPTO decisions and trademark events.
57 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2025
C71T
CANCELLED SECTION 71
11/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/25/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/25/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/25/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/25/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/15/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/30/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/23/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/23/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/13/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/24/2019
FIMP
FINAL DISPOSITION PROCESSED
08/24/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/13/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/12/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/23/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/20/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
12/20/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/20/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2018
ALIE
ASSIGNED TO LIE
12/07/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/04/2018
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/08/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/25/2018
GNSL
LETTER OF SUSPENSION E-MAILED
09/25/2018
CNSL
SUSPENSION LETTER WRITTEN
09/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/20/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/20/2018
RFNT
REFUSAL PROCESSED BY IB
04/06/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/27/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/27/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/20/2018
RFRR
REFUSAL PROCESSED BY MPU
03/20/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/13/2018
CNRT
NON-FINAL ACTION WRITTEN
03/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/10/2018
DOCK
ASSIGNED TO EXAMINER
03/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/06/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
03/01/2018
Continuous trademark protection
Get notified about every new filing that threatens LENTIGLOBIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.